Case Report: Severe Immune-Related Cholestatic Hepatitis and Subsequent Pneumonia After Pembrolizumab Therapy in a Geriatic Patient With Metastic Gastric Cancer.

Yang, Hui; Zhou, Chenfei; Yuan, Fei; Guo, Liting; Yang, Liu; Shi, Yan; Zhang, Jun

Yang, Hui; Zhou, Chenfei; Yuan, Fei; Guo, Liting; Yang, Liu; Shi, Yan; Zhang, Jun.

Afiliación

Yang H; Department of Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Zhou C; Department of Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Yuan F; Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Guo L; Department of Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Yang L; Department of Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Shi Y; Department of Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Zhang J; Department of Oncology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Front Med (Lausanne) ; 8: 719236, 2021.

Article en En | MEDLINE | ID: mdl-34712676

Palabras clave

cholestasis; immune checkpoint inhibitor; immune-mediated hepatitis; late-onset pneumonia; multisystem immune-related adverse event

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Med (Lausanne) Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google